Clinical trial
Clinical Trial of the Optimal Endpoint of Early Sepsis Resuscitation
NCT00372502 · National Institute of General Medical Sciences (NIGMS), NIH · Completed
Key facts
| NCT number | NCT00372502 |
|---|---|
| Title | Clinical Trial of the Optimal Endpoint of Early Sepsis Resuscitation |
| Official title | Lactate Assessment in the Treatment of Early Sepsis: The LactATES Trial |
| Acronym | LactATES |
| Lead sponsor | National Institute of General Medical Sciences (NIGMS), NIH |
| Status | Completed |
| Study type | Interventional |
| Conditions | Severe Sepsis, Septic Shock |
| Intervention type | Procedure |
| Interventions | Modified EGDT, Standard EGDT |
| Enrollment | 300 |
| Start date | Jan 1, 2007 |
| Primary completion | Dec 1, 2008 |
| Completion | Dec 1, 2008 |
| First posted | Sep 7, 2006 |
| Last update posted | Jan 14, 2009 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: